Clinical Trials Directory

Trials / Completed

CompletedNCT00000230

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Buprenorphine Detoxification With Two Types of Treatment. BBD III

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
University of Vermont · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine

Timeline

Start date
1995-01-01
First posted
1999-09-21
Last updated
2016-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000230. Inclusion in this directory is not an endorsement.

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 (NCT00000230) · Clinical Trials Directory